ADYNXX INC has a total of 40 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD, ATLANTIC PHARMACEUTICALS HOLDINGS LTD and PANACELA LABS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 7 | |
#3 | Japan | 6 | |
#4 | Australia | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Canada | 3 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | Hong Kong | 2 | |
#10 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Mamet Julien | 31 |
#2 | Orr Rick | 18 |
#3 | Harris Scott | 18 |
#4 | Schmidt William K | 9 |
#5 | Julien Mamet | 9 |
#6 | Yaksh Tony | 9 |
#7 | Martin William | 9 |
#8 | Yeomans David C | 9 |
#9 | Miljanich George | 9 |
#10 | Manning Don | 6 |
Publication | Filing date | Title |
---|---|---|
WO2019165361A1 | Compositions and methods for pain amelioration in patient population that scores high on the pain catastrophizing scale | |
WO2017151644A1 | Compositions and methods for pain amelioration via modification of gene expression | |
AU2016266076A1 | Gene expression and pain | |
WO2016025829A1 | Oligonucleotide decoys for the treatment of pain | |
AU2014201462A1 | Gene expression and pain | |
US2015111956A1 | Formulations for the delivery of active ingredients | |
AU2008251320A1 | Gene expression and pain |